Atlanta, Georgia — Atlanta, Georgia

Atlanta, Georgia is a clinical research site located in Atlanta, Georgia, United States 30331-2012.

Crixeo Clinical Trials Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Atlanta, Georgia has participated in 11 clinical trials with 4 currently active.

Therapeutic areas: Schizophrenia, Neurotrophic Keratopathy, Narcolepsy Type 1.

Sponsors: AbbVie, Oyster Point Pharma, Inc., Centessa Pharmaceuticals (UK) Limited.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Atlanta, Georgia?

Atlanta, Georgia has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Atlanta, Georgia conducted?

Atlanta, Georgia has 11 clinical trials on record, with 4 currently active. Their work covers Schizophrenia, Neurotrophic Keratopathy, Narcolepsy Type 1.

Is Atlanta, Georgia accredited by Crixeo Clinical Trials?

Atlanta, Georgia has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Atlanta, Georgia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.